
McNeil Consumer Healthcare Division is voluntarily recalling three lots, approximately 200,000 bottles, of Concentrated MOTRIN® Infants’ Drops Original Berry Flavor 1/2 fl oz bottles distributed in the United States.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA). McNeil is asking retailers to remove the affected lots from store shelves, and is asking consumers to stop using and dispose of any product they may have that is included in this recall.
FULL RECALLED PRODUCT LIST:
| Product | Lot # | UPC Code | Case UPC Code | 
|---|---|---|---|
| Concentrated MOTRIN® Infants’ Drops Original Berry Flavor 1/2 fl oz bottles NDC 50580-100-18  | 
            DCB3T01 | 300450524157 | 30300450524158 | 
| DDB4R01 | |||
| DDB4S01 | 
After releasing these three lots of 
Concentrated MOTRIN® Infants’ Drops Original Berry Flavor 1/2 fl oz into
 the market, tiny plastic particles (approximately 1 mm in size or about
 the size of a poppy seed) were identified in a different product lot 
during manufacturing. This lot was not released to the market. 
It was 
determined that the particles originated in a shipment from a third 
party supplier of ibuprofen, the active ingredient in Concentrated 
MOTRIN® Infants’ Drops Original Berry Flavor 1/2 fl oz. McNeil is voluntarily recalling the three lots 
released to the market made with the same batch of active ingredient as a precaution. 
McNeil has worked with the third party to ensure that corrective 
measures are in place and effective. The potential for 
adverse medical events related to the reason for this recall is not 
likely. 
Concentrated Infants’ MOTRIN® Drops Dye-Free Berry Flavor 1 fl oz is not included in this recall. Children’s or Adult MOTRIN® products are not included in this recall.
Concentrated Infants’ MOTRIN® Drops Dye-Free Berry Flavor 1 fl oz is not included in this recall. Children’s or Adult MOTRIN® products are not included in this recall.
Adverse events that may be related to the 
use of this product may be reported to U.S. Food and Drug 
Administration’s (FDA) MedWatch Adverse Event Reporting Program either 
online, by regular mail or by fax:
- Online: www.fda.gov/medwatch/report.htm
 - Regular mail: Use postage-paid, pre-addressed Form FDA 3500 available at: www.fda.gov/MedWatch/getforms.htm. Mail to address on the pre-addressed form.
 - Fax: 1-800-FDA-0178.
 
No comments:
Post a Comment